We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$14.6B
AUM Growth
+$1.24B
Cap. Flow
+$998M
Cap. Flow %
6.84%
Top 10 Hldgs %
15.27%
Holding
2,202
New
241
Increased
1,177
Reduced
603
Closed
133

Sector Composition

Rank Sector Weight
1 Energy 9.2%
2 Healthcare 8.03%
3 Technology 7.82%
4 Financials 7.64%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDCO
1451
DELISTED
Medicines Co
MDCO
$946K 0.01%
33,277
+8,304
+33% +$275K
BSFT
1452
DELISTED
BroadSoft, Inc.
BSFT
$945K 0.01%
35,368
+1,264
+4% +$36.4K
HUN icon
1453
Huntsman Corp
HUN
$1.77B
$944K 0.01%
38,670
-24,551
-39% -$570K
IGV icon
1454
iShares Expanded Tech-Software Sector ETF
IGV
$14.7B
$944K 0.01%
56,700
+860
+2% +$14.4K
DEST
1455
DELISTED
Destination Maternity Corporation
DEST
$944K 0.01%
34,450
+1,100
+3% +$30.8K
LRCX icon
1456
Lam Research
LRCX
$390B
$941K 0.01%
171,180
+13,660
+9% +$72.6K
MUX icon
1457
McEwen Inc
MUX
$1.18B
$941K 0.01%
39,716
-1,743
-4% -$46.9K
BT
1458
DELISTED
BT Group plc (ADR)
BT
$941K 0.01%
29,490
+710
+2% +$23K
EVV
1459
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$934K 0.01%
61,248
-12,186
-17% -$186K
SWZ
1460
Swiss Helvetia Fund
SWZ
$77.5M
$934K 0.01%
+64,983
New +$922K
AMBA icon
1461
Ambarella
AMBA
$3.81B
$930K 0.01%
34,811
+5,766
+20% +$177K
MTW icon
1462
Manitowoc
MTW
$675M
$929K 0.01%
32,623
+1,232
+4% +$31.6K
UI icon
1463
Ubiquiti
UI
$34.3B
$926K 0.01%
+20,372
New +$954K
USA icon
1464
Liberty All-Star Equity Fund
USA
$1.85B
$920K 0.01%
156,505
+39,024
+33% +$228K
NE
1465
DELISTED
Noble Corporation
NE
$920K 0.01%
32,162
-6,048
-16% -$171K
BIV icon
1466
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$918K 0.01%
11,014
-9,550
-46% -$794K
B
1467
Barrick Mining
B
$73.2B
$918K 0.01%
51,484
+2,570
+5% +$49.7K
PRAA icon
1468
PRA Group
PRAA
$755M
$917K 0.01%
15,843
-5,278
-25% -$284K
ALFA
1469
DELISTED
AlphaClone Alternative Alpha ETF
ALFA
$917K 0.01%
24,108
+6,080
+34% +$234K
XLKS
1470
DELISTED
POWERSHARES S&P SMALLCAP INFORMATION TECHNOLOGY PORTFOLIO
XLKS
$916K 0.01%
20,191
+1,002
+5% +$45.5K
IVZ icon
1471
Invesco
IVZ
$13.9B
$912K 0.01%
24,645
+479
+2% +$16.6K
PGX icon
1472
Invesco Preferred ETF
PGX
$3.78B
$912K 0.01%
63,967
-2,986
-4% -$41.7K
MFC icon
1473
Manulife Financial
MFC
$73.5B
$910K 0.01%
47,160
-23,998
-34% -$459K
UMPQ
1474
DELISTED
Umpqua Holdings Corp
UMPQ
$910K 0.01%
48,831
+21,818
+81% +$395K
GGME icon
1475
Invesco Next Gen Media and Gaming ETF
GGME
$46.3M
$909K 0.01%
36,572
+11,168
+44% +$287K

Similar funds

Raymond James & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Raymond James & Associates held 2,202 positions worth $14.6B, up 9.3% from $13.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $998M of net new capital in Q1 2014, opening 241 new positions and adding to 1,177 existing holdings. Its largest new stake was Edgewell Personal Care: 199,912 shares worth $14.9M.

By sector, the portfolio is most concentrated in Energy at 9.2% of assets, down from 9.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vodafone, an estimated $33.9M trimmed.

  • Raymond James & Associates's largest Q1 2014 buy was Edgewell Personal Care: 199,912 shares worth $14.9M.
  • Raymond James & Associates added most to Verizon in Q1 2014, an estimated $31.6M increase.
  • Raymond James & Associates's biggest Q1 2014 reduction was Vodafone, cutting an estimated $33.9M.
  • Raymond James & Associates fully exited Nu Skin in Q1 2014, selling an estimated $5.53M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $14.6B portfolio in Q1 2014.
  • Raymond James & Associates opened 241 new positions and closed 133 in Q1 2014.
  • Raymond James & Associates's portfolio value rose 9.3% quarter-over-quarter to $14.6B.

Based on Raymond James & Associates's 13F filing for Q1 2014, filed 13 May 2014.